AGA

Clinical trials for AGA explained in plain language.

Never miss a new study

Get alerted when new AGA trials appear

Sign up with your email to follow new studies for AGA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 3

New pill aims to reverse hair loss in women

Disease control Recruiting now

This study is testing an investigational oral pill called VDPHL01 for women with genetic hair loss (female pattern baldness). It's a large, late-stage trial comparing the drug to a placebo to see if it safely increases hair count and improves appearance. The study lasts about 13 …

Matched conditions: AGA

Phase: PHASE3 • Sponsor: Veradermics, Inc. • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

AGA

Get alerted when new AGA trials appear

New pill aims to reverse hair loss in women